Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility.
It is our mission to discover, develop, and deliver innovative therapies that improve patients' quality of life.
We work with government authorities to ensure patients have access to care while also funding medical research.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
Every day at CSL Behring, we work as if someone’s life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
Make your well-being a priority. It's important and so are you.
Rare diseases are often difficult to diagnose. We asked several patients for advice.
Experts find pros and cons to TV shows crowdsourcing for medical answers.
New global data reveals the bleeding disorder is more prevalent than previously thought, according to the World Federation of…
What was life like before diagnosis? CIDP patient Rohit picks up a brush to explain.
Replacing C1-INH plasma protein gives a rare disease a longed-for treatment.
Advocates reach a milestone in the United States, press on around the globe to save lives.
Ten years later, the Bartko family reflects on finding the right treatment and stepping forward to help others do the same.
The Undiagnosed Diseases Network seeks answers for patients with rare conditions.
Film recalls a son lost to primary immunodeficiency and the legacy built in his name.
Meet an Alpha 1 patient who advocates for others with the rare disease
On our new podcast episode, a Sickle Cell Disease patient discusses the challenges of her transition to adulthood.
Video: Catching up with one patient 10 years after her family advocated for access.
Popular search terms:
Americas
Asia Pacific
Europe
